How to inject Ozempic, Zepbound and other GLP-1s: what each label says
The short answer
Here's how to inject Ozempic, Wegovy, Saxenda and Trulicity: under the skin of the abdomen, thigh or upper arm. Zepbound and Mounjaro are different. They go in the abdomen or thigh, or in the back of the upper arm when another person gives the injection. Each label says to rotate sites.
Key takeaways
- Ozempic, Wegovy, Saxenda and Trulicity go under the skin of the abdomen, thigh or upper arm.
- Zepbound and Mounjaro differ: abdomen or thigh, or the back of the upper arm when another person gives the injection.
- Rotate sites the way your label says. That does not always mean changing body region.
- Use a new needle for every injection on a multi-dose pen, and never share a pen, even with a new needle.
- If nobody has shown you how to inject, ask. A pharmacist can walk you through the device.
On this page
- Where do you inject a GLP-1?
- Do you need to rotate injection sites?
- What time of day should you inject, and does food matter?
- Pen or vial: which form are you using?
- What about needles?
- What should the medicine look like before you inject?
- Should someone show you how before your first injection?
- Can you inject a GLP-1 alongside insulin?
- Which GLP-1 medicines are not injected?
- Frequently asked questions
- Sources
Where the labels say to inject
- AbdomenNamed on every injectable GLP-1 label.
- ThighNamed on every injectable GLP-1 label.
- Upper armOzempic, Wegovy, Saxenda and Trulicity: upper arm. Zepbound and Mounjaro: the back of the upper arm, only when another person gives the injection.
Six of the GLP-1 medicines we track are injected under the skin: Zepbound, Mounjaro, Wegovy injection, Ozempic injection, Saxenda and Trulicity. Their labels agree on most of the basics. They differ on a few details that matter, such as who may inject into the upper arm and how a weekly day can be moved. This guide sets out what each FDA label says, drug by drug. It doesn’t replace the Instructions for Use that come in your carton or the training your prescriber or pharmacist gives you.
All label statements are quoted in the sources at the bottom of the page.
Where do you inject a GLP-1?
Under the skin of the abdomen, the thigh or the upper arm. That list appears on every injectable label we hold, with one difference for Zepbound and Mounjaro.
- Wegovy, Ozempic and Saxenda (Novo Nordisk): abdomen, thigh or upper arm.
- Trulicity (Lilly): abdomen, thigh or upper arm.
- Zepbound and Mounjaro (Lilly): abdomen or thigh, or the back of the upper arm when another person gives the injection.
All of these are subcutaneous injections, meaning into the layer just under the skin. The Zepbound label says it directly: do not inject into a muscle or a vein. The Wegovy single-dose pen is labeled for subcutaneous use only.
The page on injection sites goes through each drug’s wording, including the upper arm rule and injecting near insulin.
Do you need to rotate injection sites?
Yes. Every injectable label in our records tells you to move the injection around, though the wording differs:
- Zepbound, Mounjaro, Trulicity and Wegovy: rotate injection sites with each dose.
- Ozempic: use a different injection site each week when injecting in the same body region.
- Saxenda: rotate injection sites within the same region. The Saxenda label gives a reason, which is to reduce the risk of cutaneous amyloidosis (protein deposits in the skin).
Rotating doesn’t mean you must change body region every time. The Ozempic and Saxenda wording is explicitly about choosing a new spot within the same region.
What time of day should you inject, and does food matter?
Any time of day, and food doesn’t matter for the injectables.
| Medicine | How often | Label wording on time and food |
|---|---|---|
| Zepbound | Once weekly | Any time of day, with or without meals |
| Mounjaro | Once weekly | Any time of day, with or without meals |
| Trulicity | Once weekly, same day each week | Any time of day, with or without food |
| Wegovy injection | Once weekly, same day each week | Any time of day, with or without meals |
| Ozempic injection | Once weekly, same day each week | Any time of the day, with or without meals |
| Saxenda | Once daily | Any time of day, without regard to the timing of meals |
The Wegovy label adds that the time of day and the injection site can be changed without a dosage modification. The Saxenda label says no dosage adjustment is needed if you change the injection site or the timing.
Can you change your weekly injection day?
The semaglutide labels allow it, with a minimum gap. For Wegovy, the day can change as long as your last dose was given 2 or more days before. For Ozempic, the time between two doses must be at least 2 days (more than 48 hours). The rules for the Lilly weekly injections, and what to do when a dose is missed altogether, are in the missed dose calculator, which applies each label’s rule to your dates.
Pen or vial: which form are you using?
GLP-1 injections come in three kinds of device, and the steps differ for each. Here’s what we hold from the labels.
Single-dose pens. One pen, one injection, then it’s discarded. The Wegovy single-dose pen is for 1 time use only, and Wegovy injection comes in cartons of 4 single-dose pens or 4 single-dose syringes with integrated needles. Zepbound, Mounjaro and Trulicity also come as single-dose pens.
Multi-dose pens. One pen holds several doses, and you attach a new needle each time.
- The Wegovy FlexTouch pen contains four doses of 2.4 mg.
- Ozempic pens are multi-dose. The 2 mg/3 mL pen delivers 4 doses of 0.25 mg and 2 doses of 0.5 mg, or 4 doses of 0.5 mg. The 4 mg/3 mL pen delivers 4 doses of 1 mg, and the 8 mg/3 mL pen delivers 4 doses of 2 mg.
- The Saxenda pen contains 18 mg of liraglutide, and you select a dose of 0.6 mg, 1.2 mg, 1.8 mg, 2.4 mg or 3 mg.
- The Zepbound KwikPen holds 4 weekly doses. After 4 doses the pen will prevent you from dialing a full dose, and the label says not to inject the leftover medicine.
Vials. Zepbound and Mounjaro also come in vials, which you draw up with a syringe. The labels say to use a syringe appropriate for the dose, for example a 1 mL syringe capable of measuring a 0.5 mL or 0.6 mL dose, and always a new syringe and needle for each injection.
If your prescription moves from one form to another, the Zepbound and Mounjaro labels say you should be told which presentation (form) you’ll receive and be trained for that specific one. They also say to consult the Instructions for Use for the newly prescribed presentation. The pen, vial or pill comparison shows the forms side by side, and the supply tracker works out how many doses a fill covers and when you’ll need the next one.
Who should not self-inject with a KwikPen?
The Zepbound KwikPen is not recommended for self-administration (giving it to yourself) by people who are visually impaired. The Mounjaro label says the same of its KwikPen, and adds that it is not recommended for self-administration by pediatric patients.
What about needles?
A new needle for every injection, on every multi-dose pen.
- Ozempic: NovoFine Plus 32G 4 mm disposable needles are included with the pen. The label says to always remove and safely discard the needle after each injection and to store the pen without a needle attached.
- Wegovy FlexTouch: NovoFine Plus 32G 4 mm disposable needles are included, and a new needle is used for each injection.
- Saxenda: pen needles are not included. The pen is made for disposable needles up to 8 mm long. The label says removing the needle after each injection reduces the potential for contamination, infection and leakage, and helps ensure dosing accuracy.
- Zepbound and Mounjaro vials: a new syringe and needle for each injection.
For the Zepbound or Mounjaro KwikPen, your pharmacist can tell you what is supplied with it.
Pens are never shared. The Ozempic label says each multi-dose pen is for use by a single patient and must never be shared, even if the needle is changed. The Saxenda label says the same. The sharps disposal page covers where used needles and pens go afterward.
What should the medicine look like before you inject?
The Lilly labels tell you to look before you inject:
- Zepbound and Mounjaro should appear clear and colorless to slightly yellow. Do not use the medicine if particulate matter (specks or particles) or discoloration is seen.
- Trulicity should appear clear and colorless. Do not use it if particulate matter or coloration is seen.
The Wegovy label describes the injection as a clear, colorless solution. For Ozempic and Saxenda, follow the Instructions for Use in the carton.
How a pen or vial has been stored matters as much as how it looks. A pen that has been frozen must not be used, on any of the labels we hold. The storage and travel page has each drug’s temperature limits.
Should someone show you how before your first injection?
Yes, according to the Lilly labels. The Zepbound and Mounjaro patient information says your healthcare provider should show you how to prepare and inject your dose before you inject for the first time. The Trulicity label says patients and caregivers should be trained on proper injection technique before starting, and that a healthcare provider should show you how to use the pen before the first use.
If nobody has done this, ask. A pharmacist can walk you through the device when you pick it up.
How long to hold a pen against the skin, whether to pinch the skin, and the step-by-step button sequence are in each product’s Instructions for Use.
Can you inject a GLP-1 alongside insulin?
The Ozempic, Mounjaro and Trulicity labels answer this the same way: give them as separate injections and never mix the products. It’s acceptable to inject the GLP-1 and insulin in the same body region, but the injections should not be next to each other.
Whether your insulin dose changes when you start a GLP-1 is a prescriber decision. The drug interactions page covers what each label says about insulin and sulfonylureas.
Which GLP-1 medicines are not injected?
Four of the products we track are tablets, and none of this guide’s injection steps apply to them.
- Wegovy tablets, Ozempic tablets and Rybelsus (semaglutide): one tablet once daily in the morning on an empty stomach, with up to 4 ounces of water and no other liquid. After the tablet, wait at least 30 minutes before eating, drinking or taking other oral medicines. Swallow the tablet whole.
- Foundayo (orforglipron): one tablet by mouth once daily, with or without food. Swallow it whole, and do not break, crush or chew it.
The tablet rules are strict in a different way from the injection rules, so read the guide for your medicine: Wegovy, Ozempic, Rybelsus or Foundayo.
The details for each injection are in its own guide: Zepbound, Mounjaro, Wegovy, Ozempic, Saxenda and Trulicity.
Frequently asked questions
Where do you inject Ozempic?
The Ozempic label says to inject under the skin of the abdomen, thigh or upper arm. If you keep injecting in the same body region, the label says to use a different injection site each week. Ozempic is given once weekly, on the same day each week, at any time of the day, with or without meals.
Where do you inject Zepbound?
The Zepbound label names the abdomen and the thigh for self-injection. The back of the upper arm is also a labeled site, but the label says another person should give that injection. Sites are rotated with each dose. The Mounjaro label gives the same three sites and the same instruction about the upper arm.
Can I inject Wegovy at a different time of day each week?
Yes. The Wegovy label says the injection is given once weekly, on the same day each week, at any time of day, with or without meals. It also says the time of day and the injection site can be changed without a dosage modification (no change to your dose). Changing the day of the week has its own rule: your last dose must have been given 2 or more days before.
Do you take a GLP-1 injection with food?
It doesn't matter for the injectables. The Zepbound, Mounjaro, Wegovy and Ozempic labels say with or without meals, the Trulicity label says with or without food, and the Saxenda label says without regard to the timing of meals. The tablets are different: Wegovy tablets, Ozempic tablets and Rybelsus are taken on an empty stomach in the morning.
Do GLP-1 pens come with needles?
It depends on the pen. Our label records show NovoFine Plus 32G 4 mm needles are included with the Ozempic pen and the Wegovy FlexTouch pen. Pen needles aren't included with Saxenda, which takes disposable needles up to 8 mm long. For the Zepbound or Mounjaro KwikPen, ask your pharmacist.
Can two people share a GLP-1 pen if they change the needle?
No. The Ozempic label says a pen must never be shared between patients, even if the needle is changed. The Saxenda label says the same and gives the reason: sharing may pose a risk of transmission of infection. The Zepbound and Mounjaro labels carry a warning never to share a KwikPen, and the Wegovy label carries one for the FlexTouch pen.
Are Rybelsus, Foundayo or the Wegovy pill injected?
No. They're tablets taken by mouth. Rybelsus, Ozempic tablets and Wegovy tablets are taken once daily in the morning on an empty stomach with up to 4 ounces of water. You then wait at least 30 minutes before food, drink or other oral medicines. Foundayo is taken once daily, with or without food, and swallowed whole.
Can I inject a GLP-1 in the same spot as insulin?
The Ozempic, Mounjaro and Trulicity labels say the two are given as separate injections and never mixed. It's acceptable to inject in the same body region as insulin, but the injections should not be next to each other. For Zepbound, Wegovy or Saxenda, ask your prescriber.
How do you inject Mounjaro?
The Mounjaro label says to inject under the skin of the abdomen or thigh, or to have another person inject in the back of the upper arm, and to rotate injection sites with each dose. It's given once weekly at any time of day, with or without meals. The patient information says your healthcare provider should show you how to prepare and inject your dose before the first injection.
How do you use an Ozempic pen?
The Ozempic pen is a multi-dose pen, and NovoFine Plus 32G 4 mm needles are included with it. The label says to use a new needle for each injection, to remove and safely discard the needle afterward, and to store the pen without a needle attached. The pen is never shared. The step-by-step button sequence is in the Instructions for Use in the carton.
Sources (57)
- 1.FDA label (DailyMed): Zepbound prescribing information, section 2.4
“Inject ZEPBOUND subcutaneously in the abdomen, thigh, or another person should inject in the back of the upper arm. Rotate injection sites with each dose.”
- 2.FDA label (DailyMed): Zepbound prescribing information, section 2.4
“Administer ZEPBOUND once weekly at any time of day, with or without meals.”
- 3.FDA label (DailyMed): Zepbound Medication Guide (in the prescribing information)
“Your healthcare provider should show you how to prepare to inject your dose of ZEPBOUND before injecting the first time.”
- 4.FDA label (DailyMed): Zepbound prescribing information, section 2.4
“Inform patients and their caregiver(s) which ZEPBOUND presentation (e.g., vial, prefilled single-dose pen, single-patient-use KwikPen) they will receive and ensure they receive training appropriate for that specific presentation. If the prescribed ZEPBOUND presentation changes, ensure patients and caregivers receive appropriate training and instruct them to consult the Instructions for Use for the newly prescribed presentation.”
- 5.FDA label (DailyMed): Zepbound prescribing information, section 2.4
“Inspect ZEPBOUND visually before use. It should appear clear and colorless to slightly yellow. Do not use ZEPBOUND if particulate matter or discoloration is seen.”
- 6.FDA label (DailyMed): Zepbound prescribing information, section 2.4
“Instruct patients using ZEPBOUND vials to use a syringe appropriate for dose administration (e.g., a 1 mL syringe capable of measuring a 0.5 mL or 0.6 mL dose) and always use a new syringe and needle for each injection.”
- 7.FDA label (DailyMed): Zepbound Medication Guide (in the prescribing information)
“Do not inject ZEPBOUND into a muscle (intramuscularly) or vein (intravenously).”
- 8.FDA label (DailyMed): Zepbound prescribing information, section 2.4
“ZEPBOUND KwikPen is not recommended for self-administration by those who are visually impaired.”
- 9.FDA label (DailyMed): Zepbound Instructions for Use (in the prescribing information)
“After 4 doses, throw away (discard) the Pen, including the unused medicine. The Pen will prevent you from dialing a full dose after you have given yourself 4 weekly doses. Do not inject the leftover medicine.”
- 10.FDA label (DailyMed): Mounjaro prescribing information, section 2.2
“Inject MOUNJARO subcutaneously in the abdomen, thigh, or have another person inject MOUNJARO in the back of the upper arm. Rotate injection sites with each dose.”
- 11.FDA label (DailyMed): Mounjaro prescribing information, section 2.2
“Administer MOUNJARO once weekly, any time of day, with or without meals.”
- 12.FDA label (DailyMed): Mounjaro Medication Guide (in the prescribing information)
“Your healthcare provider should show you how to prepare and inject your dose of MOUNJARO before injecting for the first time.”
- 13.FDA label (DailyMed): Mounjaro prescribing information, section 2.2
“MOUNJARO KwikPen is not recommended for self-administration by pediatric patients. MOUNJARO KwikPen is not recommended for self-administration by those who are visually impaired.”
- 14.FDA label (DailyMed): Mounjaro prescribing information, section 2.2
“Inspect MOUNJARO visually before use. It should appear clear and colorless to slightly yellow. Do not use MOUNJARO if particulate matter or discoloration is seen.”
- 15.FDA label (DailyMed): Mounjaro prescribing information, section 2.2
“Instruct patients using MOUNJARO vials to use a syringe appropriate for dose administration (e.g., a 1 mL syringe capable of measuring a 0.5 mL or 0.6 mL dose) and always use a new syringe and needle for each injection.”
- 16.FDA label (DailyMed): Mounjaro prescribing information, section 2.2
“When using MOUNJARO with insulin, administer as separate injections and never mix. It is acceptable to inject MOUNJARO and insulin in the same body region, but the injections should not be adjacent to each other.”
- 17.FDA label (DailyMed): Trulicity prescribing information, section 2.4
“Inject TRULICITY subcutaneously in the abdomen, thigh, or upper arm. Rotate injection sites with each dose.”
- 18.FDA label (DailyMed): Trulicity prescribing information, section 2.4
“Administer TRULICITY once weekly, any time of day, with or without food.”
- 19.FDA label (DailyMed): Trulicity Medication Guide (in the prescribing information)
“Use TRULICITY 1 time each week on the same day each week at any time of the day.”
- 20.FDA label (DailyMed): Trulicity prescribing information, section 2.4
“Prior to initiation, train patients and caregivers on proper injection technique [see Instructions for Use].”
- 21.FDA label (DailyMed): Trulicity prescribing information, section 2.4
“Inspect TRULICITY visually before use. It should appear clear and colorless. Do not use TRULICITY if particulate matter or coloration is seen.”
- 22.FDA label (DailyMed): Trulicity prescribing information, section 2.4
“When using TRULICITY with insulin, administer as separate injections and never mix. It is acceptable to inject TRULICITY and insulin in the same body region, but the injections should not be adjacent to each other.”
- 23.FDA label (DailyMed): Wegovy prescribing information, section 2.1
“Administer WEGOVY injection once weekly, on the same day each week, at any time of day, with or without meals.”
- 24.FDA label (DailyMed): Wegovy prescribing information, section 2.1
“Inject WEGOVY subcutaneously in the abdomen, thigh, or upper arm. The time of day and the injection site can be changed without the need for a dosage modification.”
- 25.FDA label (DailyMed): Wegovy prescribing information, section 2.1
“Rotate injection sites with each dose.”
- 26.FDA label (DailyMed): Wegovy prescribing information, Medication Guide
“If you need to change the day of the week, you may do so as long as your last dose of WEGOVY was given 2 or more days before.”
- 27.FDA label (DailyMed): Wegovy prescribing information, Instructions for Use (single-dose pen)
“Your WEGOVY pen is for 1 time use only. The WEGOVY pen is for subcutaneous (under the skin) use only.”
- 28.FDA label (DailyMed): Wegovy prescribing information, section 16
“WEGOVY injection is a clear, colorless solution available in cartons containing 4 single-dose pens, 4 single-dose syringes with integrated needles, or 1 single-patient-use pen (WEGOVY FlexTouch) as follows:”
- 29.FDA label (DailyMed): Wegovy prescribing information, Instructions for Use (FlexTouch)
“This single-patient-use pen contains four doses of WEGOVY 2.4 mg.”
- 30.FDA label (DailyMed): Wegovy prescribing information, Instructions for Use (FlexTouch)
“NovoFine® Plus 32G 4 mm disposable needles are included with your WEGOVY FlexTouch pen. Always use a new needle for each injection.”
- 31.FDA label (DailyMed): Wegovy prescribing information, section 2.1
“Take one WEGOVY tablet orally once daily on an empty stomach in the morning with water (up to 4 ounces). Do not take WEGOVY tablets with other liquids besides water”
- 32.FDA label (DailyMed): Wegovy prescribing information, section 2.1
“After taking a WEGOVY tablet, wait at least 30 minutes before eating food, drinking beverages or taking other oral medications”
- 33.FDA label (DailyMed): Ozempic prescribing information, section 2.1
“Administer OZEMPIC once weekly, on the same day each week, at any time of the day, with or without meals.”
- 34.FDA label (DailyMed): Ozempic prescribing information, section 2.1
“Inject OZEMPIC subcutaneously in the abdomen, thigh, or upper arm. Instruct patients to use a different injection site each week when injecting in the same body region.”
- 35.FDA label (DailyMed): Ozempic prescribing information, section 2.1
“When using OZEMPIC with insulin, instruct patients to administer as separate injections and to never mix the products. It is acceptable to inject OZEMPIC and insulin in the same body region, but the injections should not be adjacent to each other.”
- 36.FDA label (DailyMed): Ozempic prescribing information, section 2.1
“The day of weekly administration can be changed if necessary as long as the time between two doses is at least 2 days (>48 hours).”
- 37.FDA label (DailyMed): Ozempic prescribing information, section 3
“Injection: 2 mg/3 mL (0.68 mg/mL) for 4 doses of 0.25 mg and 2 doses of 0.5 mg or 4 doses of 0.5 mg, 4 mg/3 mL (1.34 mg/mL) for 4 doses of 1 mg, and 8 mg/3 mL (2.68 mg/mL) for 4 doses of 2 mg in single-patient-use pens”
- 38.FDA label (DailyMed): Ozempic prescribing information, section 16
“Always remove and safely discard the needle after each injection and store the OZEMPIC pen without an injection needle attached. Always use a new needle for each injection.”
- 39.FDA label (DailyMed): Ozempic prescribing information, Instructions for Use
“NovoFine® Plus 32G 4 mm disposable needles are included with your OZEMPIC pen.”
- 40.FDA label (DailyMed): Ozempic prescribing information, section 16
“Each OZEMPIC multi-dose pen is for use by a single patient. An OZEMPIC pen must never be shared between patients, even if the needle is changed”
- 41.FDA label (DailyMed): Rybelsus and Ozempic tablets prescribing information, section 2.1
“Take one RYBELSUS or OZEMPIC tablet orally once daily on an empty stomach in the morning with water (up to 4 ounces of water). Do not take RYBELSUS or OZEMPIC tablets with other liquids besides water”
- 42.FDA label (DailyMed): Rybelsus and Ozempic tablets prescribing information, section 2.1
“Swallow tablets whole. Do not split, crush, chew or dissolve in any solution.”
- 43.FDA label (DailyMed): Foundayo prescribing information, section 2.1
“Take FOUNDAYO orally once daily, with or without food.”
- 44.FDA label (DailyMed): Foundayo prescribing information, section 2.1
“Swallow tablets whole. Do not break, crush, or chew.”
- 45.FDA label (DailyMed): Saxenda prescribing information, section 2.1
“Inject SAXENDA subcutaneously once daily at any time of day, without regard to the timing of meals.”
- 46.FDA label (DailyMed): Saxenda prescribing information, section 2.1
“Inject SAXENDA subcutaneously in the abdomen, thigh, or upper arm. No dosage adjustment is needed if changing the injection site and/or timing.”
- 47.FDA label (DailyMed): Saxenda prescribing information, section 2.1
“Rotate injection sites within the same region in order to reduce the risk of cutaneous amyloidosis”
- 48.FDA label (DailyMed): Saxenda prescribing information, Instructions for Use
“It contains 18 mg of liraglutide, and you can select doses of 0.6 mg, 1.2 mg, 1.8 mg, 2.4 mg and 3 mg.”
- 49.FDA label (DailyMed): Saxenda prescribing information, Instructions for Use
“Your pen is made to be used with disposable needles up to a length of 8 mm. Pen needles are not included with your Saxenda pen.”
- 50.FDA label (DailyMed): Saxenda prescribing information, section 16
“Always remove and safely discard the needle after each injection and store the SAXENDA pen without an injection needle attached. This will reduce the potential for contamination, infection, and leakage while also ensuring dosing accuracy.”
- 51.FDA label (DailyMed): Saxenda prescribing information, section 17
“Inform patients that they should never share a SAXENDA pen with another person, even if the needle is changed. Sharing of the pen between patients may pose a risk of transmission of infection.”
- 52.FDA label (DailyMed): Zepbound prescribing information, section 16.2
“Do not freeze ZEPBOUND. Do not use ZEPBOUND if frozen. Protect ZEPBOUND from heat and light. Store ZEPBOUND in the original carton to protect from light.”
- 53.FDA label (DailyMed): Mounjaro prescribing information, section 16.2
“Do not freeze MOUNJARO. Do not use MOUNJARO if frozen. Protect MOUNJARO from heat and light. Store MOUNJARO in the original carton to protect from light.”
- 54.FDA label (DailyMed): Trulicity prescribing information, section 16.2
“Do not freeze TRULICITY. Do not use TRULICITY if it has been frozen.”
- 55.FDA label (DailyMed): Wegovy prescribing information, section 16
“Do not freeze WEGOVY and do not use if it has been frozen.”
- 56.FDA label (DailyMed): Ozempic prescribing information, section 16
“Do not freeze OZEMPIC and do not use OZEMPIC if it has been frozen. OZEMPIC must be kept in the original carton until time of administration.”
- 57.FDA label (DailyMed): Saxenda prescribing information, section 16
“Do not freeze SAXENDA and do not use SAXENDA if it has been frozen.”
Related pages
- Where to inject Ozempic, Zepbound, Mounjaro and Wegovy
- Does Zepbound need to be refrigerated? Storage and travel rules for every GLP-1
- How to dispose of Ozempic pens and other GLP-1 pens and needles
- What is Zepbound? Uses, cost, doses and side effects
- What is Wegovy? Uses, doses, pill and pen, and cost
- What is Ozempic? Uses, doses, cost and how to take it
